Authors: SYNOLD TW NEWMAN EM CARROLL M MUGGIA FM GROSHEN S JOHNSON K DOROSHOW JH

Citation: Tw. Synold et al., CELLULAR BUT NOT PLASMA PHARMACOKINETICS OF LOMETREXOL CORRELATE WITHTHE OCCURRENCE OF CUMULATIVE HEMATOLOGICAL TOXICITY, Clinical cancer research, 4(10), 1998, pp. 2349-2355

Authors: MORGAN RJ NEWMAN EM DOROSHOW JH MCGONIGLE K MARGOLIN K RASCHKO J CHOW W SOMLO G LEONG L TETEF M SHIBATA S HAMASAKI V CARROLL M VASILEV S AKMAN S COLUZZI P WAGMAN L LONGMATE J PAZ B YEN Y KLEVECZ R

Citation: Rj. Morgan et al., PHASE-I TRIAL OF INTRAPERITONEAL IODODEOXYURIDINE WITH AND WITHOUT INTRAVENOUS HIGH-DOSE FOLINIC ACID IN THE TREATMENT OF ADVANCED MALIGNANCIES PRIMARILY CONFINED TO THE PERITONEAL-CAVITY - FLOW CYTOMETRIC ANDPHARMACOKINETIC ANALYSIS, Cancer research, 58(13), 1998, pp. 2793-2800

Authors: NEWMAN EM CARROLL M AKMAN SA CHOW W COLUZZI P HAMASAKI V LEONG LA MARGOLIN KA MORGAN RJ RASCHKO JW SHIBATA S SOMLO G TETEF M YEN Y AHN CW DOROSHOW JH

Citation: Em. Newman et al., PHARMACOKINETICS AND TOXICITY OF 120-HOUR CONTINUOUS-INFUSION HYDROXYUREA IN PATIENTS WITH ADVANCED SOLID TUMORS, Cancer chemotherapy and pharmacology, 39(3), 1997, pp. 254-258

Authors: MUGGIA FM SYNOLD TW NEWMAN EM JEFFERS S LEICHMAN LP DOROSHOW JH JOHNSON K GROSHEN S

Citation: Fm. Muggia et al., FAILURE OF PRETREATMENT WITH INTRAVENOUS FOLIC-ACID TO ALTER THE CUMULATIVE HEMATOLOGIC TOXICITY OF LOMETREXOL, Journal of the National Cancer Institute, 88(20), 1996, pp. 1495-1496

Authors: SYNOLD TW XI BX NEWMAN EM MUGGIA FM DOROSHOW JH

Citation: Tw. Synold et al., SIMPLE AND SENSITIVE METHOD FOR THE QUANTITATIVE-ANALYSIS OF LOMETREXOL IN PLASMA USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION, Journal of chromatography B. Biomedical applications, 683(2), 1996, pp. 245-249

Authors: HAGEBOUTROS A ROGATKO A NEWMAN EM MCALEER C BRENNAN J LACRETA FP HUDES GR OZOLS RF ODWYER PJ

Citation: A. Hageboutros et al., PHASE-I STUDY OF PHOSPHONACETYL-L-ASPARTATE, 5-FLUOROURACIL, AND LEUCOVORIN IN PATIENTS WITH ADVANCED CANCER, Cancer chemotherapy and pharmacology, 35(3), 1995, pp. 205-212